Tarsus Pharmaceuticals
TARS
$38.24
Share price
-0.88%
Change (1 day)
140.05%
Change (1 year)
Categories
P/S ratio for Tarsus Pharmaceuticals (TARS)
P/S ratio as of May 2024 (TTM): 83.5
According to Tarsus Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 83.5455. At the end of 2023 the company had a P/S ratio of 38.4.
P/S ratio history for Tarsus Pharmaceuticals from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 38.4 | 153.68% |
| 2022 | 15.1 | 85.66% |
| 2021 | 8.16 | |
| 2020 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |